journal article·2024-10Open access

Sphingosine Kinase 2 Regulates Aryl Hydrocarbon Receptor Nuclear Translocation and Target Gene Activation

Shigetoshi Yokoyama, Imhoi Koo, Daisuke Aibara, Yuan Tian, Iain A. Murray, Stephanie L. Collins, Denise M. Coslo, Mari Kono, Jeffrey M. Peters, Richard L. Proia, Frank J. Gonzalez, Gary H. Perdew, Andrew D. Patterson

Advanced Science· Volume 11· Issue 40

Abstract

Abstract Sphingolipids play vital roles in metabolism and regulation. Previously, the aryl hydrocarbon receptor (AHR), a ligand‐activated transcription factor, was reported to directly regulate ceramide synthesis genes by binding to their promoters. Herein, sphingosine kinase 2 (SPHK2), responsible for producing sphingosine‐1‐phosphate (S1P), was found to interact with AHR through LXXLL motifs, influencing AHR nuclear localization. Through mutagenesis and co‐transfection studies, AHR activation and subsequent nuclear translocation was hindered by SPHK2 LXXLL mutants or SPHK2 lacking a nuclear localization signal (NLS). Similarly, an NLS‐deficient AHR mutant impaired SPHK2 nuclear translocation. Silencing SPHK2 reduced AHR expression and its target gene CYP1A1, while SPHK2 overexpression enhanced AHR activity. SPHK2 was found enriched on the CYP1A1 promoter, underscoring its role in AHR target gene activation. Additionally, S1P rapidly increased AHR expression at both the mRNA and protein levels and promoted AHR recruitment to the CYP1A1 promoter. Using mouse models, AHR deficiency compromised SPHK2 nuclear translocation, illustrating a critical interaction where SPHK2 facilitates AHR nuclear localization and supports a positive feedback loop between AHR and sphingolipid enzyme activity in the nucleus. These findings highlight a novel function of SPHK2 in regulating AHR activity and gene expression.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Sphingolipid Metabolism and Signaling · Endoplasmic Reticulum Stress and Disease · Biochemical Acid Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Veterinary and Biomedical Sciences Pennsylvania State University University Park PA 16802 USA

Cancer Innovation Laboratory Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD 20892 USA

Department of Biochemistry and Molecular Biology Pennsylvania State University University Park PA 16802 USA

Genetics and Biochemistry Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD 20892 USA

Funding

Fukuoka Public Health Promotion Organization Cancer Research Fund · National Institute of Food and Agriculture · NIH Office of the Director · National Institute of Environmental Health Sciences

References (49)

Show source-provided references
1. 10.1038/s41467-022-35199-010.1038/s41467-022-35199-0 ↗
2. 10.3390/medicina5707072910.3390/medicina57070729 ↗
3. 10.1038/s42255-019-0134-810.1038/s42255-019-0134-8 ↗
4. 10.1007/BF0253891610.1007/BF02538916 ↗
5. 10.1006/bbrc.1997.680310.1006/bbrc.1997.6803 ↗
6. 10.1016/S0168-8278(01)00301-410.1016/S0168-8278(01)00301-4 ↗
7. 10.1016/j.bbalip.2009.03.01610.1016/j.bbalip.2009.03.016 ↗
8. 10.4161/cib.2.1.737610.4161/cib.2.1.7376 ↗
9. 10.1002/jcb.2670710.1002/jcb.26707 ↗
10. 10.1038/nrc384610.1038/nrc3846 ↗
11. 10.1016/S0021-9258(18)47020-210.1016/S0021-9258(18)47020-2 ↗
12. 10.1074/jbc.274.19.1351910.1074/jbc.274.19.13519 ↗
13. 10.1124/dmd.115.06424610.1124/dmd.115.064246 ↗
14. 10.1016/j.immuni.2018.07.01010.1016/j.immuni.2018.07.010 ↗
15. 10.1016/j.immuni.2011.11.01110.1016/j.immuni.2011.11.011 ↗
16. 10.1089/scd.2021.009610.1089/scd.2021.0096 ↗
17. 10.1016/j.labinv.2022.10001210.1016/j.labinv.2022.100012 ↗
18. 10.1038/jid.2015.610.1038/jid.2015.6 ↗
19. 10.1016/j.tox.2021.15283110.1016/j.tox.2021.152831 ↗
20. 10.1074/jbc.AC119.01117010.1074/jbc.AC119.011170 ↗
21. 10.1016/j.celrep.2017.12.09010.1016/j.celrep.2017.12.090 ↗
22. 10.1111/j.1399-3011.2004.00126.x10.1111/j.1399-3011.2004.00126.x ↗
23. 10.1016/j.tibs.2004.12.00110.1016/j.tibs.2004.12.001 ↗
24. 10.1074/jbc.274.44.3132010.1074/jbc.274.44.31320 ↗
25. Kumar M. B. · Gene Expr. · 1999 · 8 · 273
26. 10.1016/j.jmb.2003.12.05710.1016/j.jmb.2003.12.057 ↗
27. 10.1016/j.abb.2008.01.01410.1016/j.abb.2008.01.014 ↗
28. 10.1038/4275010.1038/42750 ↗
29. 10.1074/jbc.M70164120010.1074/jbc.M701641200 ↗
30. 10.1074/jbc.M30657720010.1074/jbc.M306577200 ↗
31. 10.1093/jb/mvx07410.1093/jb/mvx074 ↗
32. 10.1016/j.jlr.2022.10022510.1016/j.jlr.2022.100225 ↗
33. 10.1124/jpet.109.16344410.1124/jpet.109.163444 ↗
34. 10.1126/science.117670910.1126/science.1176709 ↗
35. 10.1016/j.prostaglandins.2005.06.00810.1016/j.prostaglandins.2005.06.008 ↗
36. 10.1177/1177391X070010000210.1177/1177391X0700100002 ↗
37. 10.1016/S0009-3084(99)00081-X10.1016/S0009-3084(99)00081-X ↗
38. 10.1021/bi035706v10.1021/bi035706v ↗
39. 10.1038/nrm110310.1038/nrm1103 ↗
40. 10.7554/eLife.2199210.7554/eLife.21992 ↗
41. 10.1210/en.2006-035510.1210/en.2006-0355 ↗
42. 10.1096/fj.201901734RR10.1096/fj.201901734RR ↗
43. Farooqui A. A. · Neurosci. Rev. J. Bring. Neurobiol. Neurol. Psych. · 2009 · 15 · 392
44. 10.1038/onc.2008.46810.1038/onc.2008.468 ↗
45. 10.1038/nrc339810.1038/nrc3398 ↗
46. 10.1194/jlr.S09118110.1194/jlr.S091181 ↗
47. 10.1021/bi050948b10.1021/bi050948b ↗
48. 10.1289/ehp.140905510.1289/ehp.1409055 ↗
49. 10.1016/0003-9861(91)90136-710.1016/0003-9861(91)90136-7 ↗